Biochemist at the Bioengineering in Reproductive Health Research Group
Reference: LT-SO / Until Oct 15th, 2022
Reference: LT-SO / Until Oct 15th, 2022
Ref:. CMM-IO / Fins el 9 de Setembre
Introduction to the vacant position: The Nanomalaria Group is looking for an Early Stage Researcher (PhD student) to develop his/her PhD thesis project on the development of new antimalarial drugs. … Read more
Introduction to the vacant position: The Smart Nano-Bio-Devices Group is looking for an Postdoctoral Researcher to work on the development of enzyme-nanomotors for translational approaches within biomedicine. The contract will … Read more
Introduction to the vacant position: The Smart Nano-Bio-Devices Group is looking for an Postdoctoral Researcher to work on the development of enzyme-nanomotors for translational approaches within biomedicine. The contract will … Read more
Introduction to the vacant position: The Pluripotency for organ regeneration Group at the Institute for Bioengineering of Catalonia (IBEC) led by Prof. Nuria Montserrat is looking for a laboratory technician … Read more
Introducció a la posició vacant: L’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/-a People Administrative Officer per tal de donar suport a la Unitat de Recursos Humans. Principals tasques … Read more
Introduction to the vacant position: The Pluripotency for organ regeneration Group is looking for a Postdoc to develop his/her project on the fabrication of microfluidic devices for tissue engineered organ-on-a-chip … Read more
Introduction to the vacant position: The Smart Nano-Bio-Devices Group is looking for (2) two Early Stage Researcher (PhD students) to develop their PhD thesis project on the development of self-propelled … Read more
Application Deadline: 23/09/2022
Ref: PD-NM
The Pluripotency for organ regeneration group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral researcher to develop his/her project on the fabrication of microfluidic devices for tissue engineered organ-on-a-chip cultures during health and upon SARS-CoV-2 infection.
The contract will be within the framework of “Modern approaches for developing antivirals against SARS-CoV 2” from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement no. 101005026 .